California Oncology Weekly Newsletter 9.19.2017

Blog Pic

This Weekly’s Hot Topics

  • 5 UC cancer centers collaborate to improve cancer care (California News)
  • Share your PBM story with the New York Times (National News)
  • ASCO’s Leadership Development Program applications due 09/24 (Affiliate News)


Californians Allied for Patient Protection (CAPP) The Coalition to Protect MICRA, (you know, the coalition that fights for your reduced malpractice premium rates) invite you to join them for an evening reception in honor of Senator Scott Wiener on Monday, September 25th from 5:30 p.m. – 6:30 p.m. For more information click here and go to California News.

COPA (Community Oncology Pharmacists Association) has been heavily involved in the PBM issue for more than a year.  In recent months, anger over rising drug costs set off a civil war within the pharmaceutical industry, pitting drug makers against other players in the health care system, including the little-known pharmacy benefits managers that negotiate with drug makers on behalf of insurers, large employers and government health programs. For more information click here and go to National News.

Year In Review, moderated by Neil Love, M.D., is a multi-tumor regional symposia series focused on the application of emerging research information to the care of patients with common cancers, is scheduled for Saturday, November 18, 2017 at the Fairmont Miramar Hotel in Santa Monica, CA. For more information click here and go to Affiliate News.

Applications for ASCO’s Leadership Development Program will be accepted through September 24. Through the Program, participants will gain extensive exposure to the roles and mission of ASCO, its Leadership, and the Society’s powerful place in developing the future of cancer care. Applicants must have completed their final subspecialty training between 2008 and 2013. For more information click here and go to Affiliate News.

To view the complete California Oncology Weekly Newsletter, click on the date below.

September 19, 2017

No comments have been posted yet.